NMDA receptor antagonist
NMDA receptor antagonist
The NMDA receptor antagonist is a type of drug that inhibits the action of the N-Methyl-D-aspartate receptor (NMDAR). This receptor is a subtype of glutamate receptor, which is the most abundant excitatory neurotransmitter in the human brain. NMDA receptor antagonists are used in the treatment of a variety of medical conditions, including neurodegenerative diseases, psychiatric disorders, and pain management.
Mechanism of Action
NMDA receptor antagonists work by binding to the NMDAR, thereby blocking the action of glutamate. This prevents the influx of calcium ions into the neuron, which in turn inhibits neuronal excitation. This mechanism of action is crucial in conditions where excessive neuronal excitation is implicated, such as in epilepsy and neurodegenerative diseases.
Clinical Uses
NMDA receptor antagonists have a wide range of clinical applications. They are used in the treatment of Alzheimer's disease, Parkinson's disease, and Huntington's disease, where they help to slow down the progression of these neurodegenerative conditions. In psychiatry, NMDA receptor antagonists are used in the management of conditions such as schizophrenia, depression, and bipolar disorder. They are also used in pain management, particularly in the treatment of neuropathic pain.
Side Effects and Risks
While NMDA receptor antagonists are generally well-tolerated, they can cause a range of side effects. These include dizziness, nausea, vomiting, and hallucinations. In rare cases, they can cause serious complications such as psychosis and neurotoxicity. It is therefore important that these drugs are used under the supervision of a healthcare professional.
Research and Development
Research into NMDA receptor antagonists is ongoing, with scientists exploring their potential use in other conditions such as addiction, stroke, and traumatic brain injury. There is also interest in developing new NMDA receptor antagonists with fewer side effects and greater efficacy.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen